AI Market Mood: Stock Dashboard
AVXL
Fundamental
Company: Anavex Life Sciences Corporation
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.51
Insider Own: 3.18%
Shs Outstand: 84.80M
Perf Week: 6.42%
Market Cap: 969.44M
Forward P/E: 4.86
EPS next Y: 2.35
Insider Trans: 0.00%
Shs Float: 82.12M
Perf Month: 40.42%
Income: -43.00M
PEG: -
EPS next Q: -0.15
Inst Own: 31.88%
Short Float: 25.35%
Perf Quarter: 118.13%
Sales: 0.00M
P/S: -
EPS this Y: -16.03%
Inst Trans: 1.20%
Short Ratio: 12.30
Perf Half Y: 147.40%
Book/sh: 1.42
P/B: 8.06
EPS next Y Percentage: 489.50%
ROA: -29.66%
Short Interest: 20.82M
Perf Year: 74.24%
Cash/sh: 1.56
P/C: 7.33
EPS next 5Y: -
ROE: -32.81%
52W Range From: 3.25
52W Range To: 14.44
Perf YTD: 6.42%
Dividend Est.: -
P/FCF: -
EPS past 5Y: 0.85%
ROI: -35.76%
52W High: -20.85%
Beta: 0.70
Dividend TTM: -
Quick Ratio: 8.86
Sales past 5Y: 0.00%
Gross Margin: -
52W Low: 251.69%
ATR (14): 1.26
Dividend Ex-Date: -
Current Ratio: 8.86
EPS Y/Y TTM: 13.82%
Oper. Margin: -
RSI (14): 55.79
Volatility W: 11.60%
Volatility M: 11.68%
Employees: 42
Debt/Eq: 0.00
Sales Y/Y TTM: -
Profit Margin: -
Recom: 1.00
Target Price: 34.33
Option/Short: Yes / No
LT Debt/Eq: 0.00
EPS Q/Q: -10.66%
Payout: -
Rel Volume: 1.98
Prev Close: 13.46
Sales Surprise: -
EPS Surprise: 14.27%
Sales Q/Q: -
Earnings: Dec 23 BMO
Avg Volume: 1.69M
Price: 11.43
SMA20: 9.64%
SMA50: 26.52%
SMA200: 90.76%
Trades:
Volume: 3,355,474
Change: -15.08%
Technical:
Latest News:
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral
ANVS AVXL LGVN
Summary: Annovis Bio Inc. will participate in the H.C. Wainwright 26th Annual Global Investment Conference with a company presentation by Dr. Maccecchini discussing recent advancements and strategic direction, followed by a panel discussion on innovative non-amyloid approaches in Alzheimer’s disease.
Full article2024-09-05T13:33:22Z